Galderma Group AG (GALDY)
OTCMKTS · Delayed Price · Currency is USD
24.49
-0.09 (-0.37%)
May 13, 2025, 9:30 AM EDT

Revenue by Product

Fiscal year is January - December.
Year Ending
TTM Dec '24 Dec '23 Dec '22 Dec '21
Neuromodulators
1.33B
Log In
Log In
Log In
Log In
Neuromodulators Growth
10.44%
Log In
Log In
Log In
Log In
Fillers & Biostimulators
1.00B
Log In
Log In
Log In
Log In
Fillers & Biostimulators Growth
0%
Log In
Log In
Log In
Log In
Injectable Aesthetics
2.34B
Log In
Log In
Log In
Log In
Injectable Aesthetics Growth
5.70%
Log In
Log In
Log In
Log In
Dermatological Skincare
1.35B
Log In
Log In
Log In
Log In
Dermatological Skincare Growth
9.14%
Log In
Log In
Log In
Log In
Therapeutic Dermatology
783.00M
Log In
Log In
Log In
Log In
Therapeutic Dermatology Growth
3.98%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Year Ending
TTM Dec '24 Dec '23 Dec '22 Dec '21
USA
1.83B
Log In
Log In
Log In
Log In
USA Growth
-0.22%
Log In
Log In
Log In
Log In
International
2.64B
Log In
Log In
Log In
Log In
International Growth
11.60%
Log In
Log In
Log In
Log In

Other

Fiscal year is January - December.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21
Neuromodulators Constant Currency Growth
Log In
Log In
Log In
Log In
Fillers & Biostimulators Constant Currency Growth
Log In
Log In
Log In
Log In
Injectable Aesthetics Constant Currency Growth
Log In
Log In
Log In
Log In
Dermatological Skincare Constant Currency Growth
Log In
Log In
Log In
Log In
Therapeutic Dermatology Constant Currency Growth
Log In
Log In
Log In
Log In
Total Constant Currency Growth
Log In
Log In
Log In
Log In